322 filings
8-K
NAOV
NanoVibronix Inc
16 May 24
NanoVibronix Issues Letter to Stockholders
4:05pm
10-Q
2024 Q1
NAOV
NanoVibronix Inc
Quarterly report
15 May 24
1:25pm
10-K/A
2023 FY
NAOV
NanoVibronix Inc
Annual report (amended)
26 Apr 24
4:05pm
8-K
NAOV
NanoVibronix Inc
15 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
10-K/A
2023 FY
NAOV
NanoVibronix Inc
Annual report (amended)
9 Apr 24
5:15pm
8-K
bx57hw0dmux9haxxx5
9 Apr 24
NanoVibronix Issues Letter to Stockholders
4:05pm
NT 10-K
csu4pn06 msb8
1 Apr 24
Notice of late annual filing
4:30pm
8-K
rlnnti55fb0f2vlptqmf
28 Mar 24
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
9:09am
DEFA14A
ymb53hf4wb7c8e5xc
17 Jan 24
Additional proxy soliciting materials
4:31pm
8-K
wre0y6nqsnps9ovrly4
17 Jan 24
Other Events
4:30pm
8-K
4nksrn
11 Dec 23
Changes in Registrant's Certifying Accountant
4:30pm
8-K
xs7j80tre6 kb1qvu
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
DEFA14A
1qao5 tbu
29 Nov 23
Additional proxy soliciting materials
8:43pm
8-K
7eoz6
28 Nov 23
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
9:00am
8-K
ct3y5daniu
21 Nov 23
Other Events
8:30am
8-K
xhkf 16141
14 Nov 23
NanoVibronix Issues Letter to Shareholders
12:00am
8-K
7wluhjf
7 Nov 23
Receives Stocking Order from U.K. Distribution Partner in Anticipation of Increasing Demand
8:30am